Comprehensive review on betulin as a potent anticancer agent SK Król, M Kiełbus, A Rivero-Müller, A Stepulak BioMed research international 2015 (1), 584189, 2015 | 270 | 2015 |
Expression of glutamate receptor subunits in human cancers A Stepulak, H Luksch, C Gebhardt, O Uckermann, J Marzahn, M Sifringer, ... Histochemistry and cell biology 132, 435-445, 2009 | 238 | 2009 |
Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain HH Hansen, T Briem, M Dzietko, M Sifringer, A Voss, W Rzeski, ... Neurobiology of disease 16 (2), 440-453, 2004 | 211 | 2004 |
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity N Tanaka, S Kanatani, R Tomer, C Sahlgren, P Kronqvist, D Kaczynska, ... Nature Biomedical Engineering 1 (10), 796-806, 2017 | 197 | 2017 |
Glutamate and its receptors in cancer A Stepulak, R Rola, K Polberg, C Ikonomidou Journal of neural transmission 121, 933-944, 2014 | 182 | 2014 |
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells W Rzeski, A Stepulak, M Szymański, M Sifringer, J Kaczor, K Wejksza, ... Naunyn-Schmiedeberg's archives of pharmacology 374, 11-20, 2006 | 180 | 2006 |
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth A Stepulak, M Sifringer, W Rzeski, S Endesfelder, A Gratopp, EE Pohl, ... Proceedings of the National Academy of Sciences 102 (43), 15605-15610, 2005 | 178 | 2005 |
The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase T He, A Stepulak, TH Holmström, MB Omary, JE Eriksson Journal of Biological Chemistry 277 (13), 10767-10774, 2002 | 157 | 2002 |
Glutamate receptors in pediatric tumors of the central nervous system KS Brocke, C Staufner, H Luksch, KD Geiger, A Stepulak, J Marzahn, ... Cancer biology & therapy 9 (6), 455-468, 2010 | 138 | 2010 |
Silencing of selected glutamate receptor subunits modulates cancer growth H Luksch, O Uckermann, A Stepulak, S Hendruschk, J Marzahn, ... Anticancer research 31 (10), 3181-3192, 2011 | 113 | 2011 |
MicroRNAs‐role in lung cancer M Guz, A Rivero-Müller, E Okoń, A Stenzel-Bembenek, K Polberg, ... Disease markers 2014 (1), 218169, 2014 | 97 | 2014 |
Betulin Elicits Anti‐Cancer Effects in Tumour Primary Cultures and Cell Lines In Vitro W Rzeski, A Stepulak, M Szymański, M Juszczak, A Grabarska, ... Basic & clinical pharmacology & toxicology 105 (6), 425-432, 2009 | 96 | 2009 |
Histone deacetylase inhibitors and phenotypical transformation of cancer cells A Wawruszak, J Kalafut, E Okon, J Czapinski, M Halasa, ... Cancers 11 (2), 148, 2019 | 94 | 2019 |
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells A Stepulak, W Rzeski, M Sifringer, K Brocke, A Gratopp, K Kupisz, L Turski, ... Cancer biology & therapy 7 (10), 1685-1693, 2008 | 94 | 2008 |
Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood A Szuster-Ciesielska, E Hryciuk-Umer, A Stepulak, K Kupisz, ... Acta oncologica 43 (3), 252-258, 2004 | 90 | 2004 |
Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines–An isobolographic analysis A Wawruszak, JJ Luszczki, A Grabarska, E Gumbarewicz, ... PLoS One 10 (11), e0143013, 2015 | 78 | 2015 |
The role of matrix metalloproteinases in infant traumatic brain injury M Sifringer, V Stefovska, I Zentner, B Hansen, A Stepulak, C Knaute, ... Neurobiology of disease 25 (3), 526-535, 2007 | 77 | 2007 |
H3K18Ac as a marker of cancer progression and potential target of anti-cancer therapy M Hałasa, A Wawruszak, A Przybyszewska, A Jaruga, M Guz, J Kałafut, ... Cells 8 (5), 485, 2019 | 66 | 2019 |
Valproic acid and breast cancer: State of the art in 2021 A Wawruszak, M Halasa, E Okon, W Kukula-Koch, A Stepulak Cancers 13 (14), 3409, 2021 | 65 | 2021 |
Superior anticancer activity is demonstrated by total extract of Curcuma longa L. as opposed to individual curcuminoids separated by centrifugal partition … W Kukula‐Koch, A Grabarska, J Łuszczki, L Czernicka, E Nowosadzka, ... Phytotherapy Research 32 (5), 933-942, 2018 | 59 | 2018 |